NCT02804282View on ClinicalTrials.gov

Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Heart Failure
Interventions
COMBINATION_PRODUCT

sc2Wear Furosemide

Drug-device combination product of buffered furosemide injection, (Furosemide Injection Solution), 8 mg/mL, and patch pump (sc2Wear Furosemide Pump)

All Listed Sponsors
lead

scPharmaceuticals, Inc.

INDUSTRY

NCT02804282 - Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product | Biotech Hunter | Biotech Hunter